天津武清龙济医院男子医院主页(武清龙济医院门诊好吗) (今日更新中)

ATLANTA (KGTV) - An Atlanta Delta flight was forced to return to the ground shortly after takeoff when black smoke began billowing from one of its engines.The Delta aircraft took off from Hartsfield-Jackson Atlanta International Airport Wednesday shortly after 6 p.m. EDT when the smoke was reported, according to airport officials. Multiple reports indicate the plane was heading for London's Heathrow Airport.About 43 minutes after takeoff, the plane returned to the ground and airport fire crews hosed down the engine. The plane was then towed back to its terminal.RELATED: Southwest passenger is first to die on a US airline since 2009No injuries were reported and the airport endured "minimal impact" to other operations, officials said.The emergency landing occurs one day after a Southwest Airlines plane blew an engine while traveling from New York to Dallas and was forced to land in Philadelphia.Jennifer Riordan, 43, was struck by shrapnel from the engine and partially sucked out of a window. She later died from her injuries. Seven other passengers were also injured in the incident. 1144

As vaccinations get underway in the United Kingdom, United States and other rich countries who could afford to pre-purchase doses of the COVID-19 vaccines, researchers warn that about a quarter of the world’s population will be unable to be vaccinated until 2022.There are 13 vaccine manufacturers working on coronavirus vaccines, and they are capable of producing around 6 billion courses of vaccine by the end of 2021.“Just over half (51%) of these doses will go to high income countries, which represent 14% of the world’s population,” researchers from the Johns Hopkins Bloomberg School of Public Health wrote in their report, published in the British Medical Journal."Of the 13 manufacturers, only six have sold to low and middle-income countries,” they noted.At the time of the report, the U.S. had reserved 800 million doses of the vaccine. Japan and Australia, which account for fewer than 1% of the world’s COVID-19 cases, have reserved and potential options to get 1 billion doses.“Even if all 13 of these vaccine manufacturers were to succeed in reaching their maximum production capacity, at least a fifth of the world’s population would not have access to vaccines until 2022,” researchers noted.Covax, a global effort organized by the World Health Organization, had made initial purchases of 300 million vaccine doses. Covax is working to create equitable access to COVID-19 tests, treatments and vaccines for all countries. President Donald Trump’s administration said they would not participate in the effort."This study provides an overview of how high-income countries have secured future supplies of COVID-19 vaccines, but that access for the rest of the world is uncertain," the researchers concluded. "Governments and manufacturers might provide much-needed assurances for the equitable allocation of COVID-19 vaccines through greater transparency and accountability over these arrangements." 1921

As President Donald Trump calls for more help for those with mental health issues in the wake of the Parkland high school shooting, Congress is considering a bill that would create a three-digit suicide and mental health hotline.Introducing the legislation on the Senate floor in May, Sen. Orrin Hatch said constituents have told him that friends and family who've struggled with suicidal thoughts don't always know where to turn."To make matters worse, the national suicide hotline number, 1-800-273-TALK, is not an intuitive or easy number to remember, particularly for those experiencing a mental health emergency," the Utah Republican said.Hatch gave the example of one young Utah woman who tried to call her counselor before her suicide -- but couldn't reach her."I believe that by making the National Suicide Prevention Lifeline system more user-friendly and accessible, we can save thousands of lives by helping people find the help they need when they need it most," he said.Record increases in suicide rate 1023

As questions arise over when a coronavirus vaccine should be granted FDA approval, the leaders of several major pharmaceutical companies announced they have signed a pledge not to rush the development of a vaccine.The companies, AstraZeneca, BioNTech, GlaxoSmithKline, Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi, released a joint statement on Tuesday confirming the pledge.The pledge includes the following points:Always make the safety and well-being of vaccinated individuals our top priority.Continue to adhere to high scientific and ethical standards regarding the conduct of clinical trials and the rigor of manufacturing processes.Only submit for approval or emergency use authorization after demonstrating safety and efficacy through a Phase 3 clinical study that is designed and conducted to meet requirements of expert regulatory authorities such as FDA.Work to ensure a sufficient supply and range of vaccine options, including those suitable for global access.There has been pressure on both the FDA and manufactures to develop and approve a vaccine for the coronavirus. There have been more than 190,000 coronavirus-related deaths in the US since March, and the economic impact of the virus has cost millions of jobs.While most developed countries have not had the same public health pain as the US, the economic impact of the virus has been felt worldwide. The International Monetary Fund estimates a nearly 5% loss in global GDP in 2020.In Russia, the country claimed to begin distributing a coronavirus vaccine despite US-based vaccine candidates likely being months away from being able to demonstrate efficacy.The pressure domestically has also ratcheted up as President Donald Trump has suggested a vaccine could be ready by this fall’s presidential election."We're going to have a vaccine very soon... maybe even before a very special date, you know what date I'm talking about,” Trump said on Monday.In late August, the CDC told states to begin to prepare distributing a vaccine by Nov. 1. But Surgeon General Jerome Adams said that just because states will be ready to help distribute a vaccine on Nov. 1 does not mean a vaccine will be ready by then."We've always said that we're hopeful for a vaccine by the end of this year or the beginning of next year,” Adams told Good Morning America."We want to make sure states are available to distribute it," he added.The companies signing on the pledge said that the FDA has strict protocols for vaccine candidates. A typical vaccine trial takes one to three years, but the companies believe only a safe and effective vaccine will be granted approval.“FDA has established clear guidance for the development of COVID-19 vaccines and clear criteria for their potential authorization or approval in the US,” the companies wrote in the pledge. “FDA’s guidance and criteria are based on the scientific and medical principles necessary to clearly demonstrate the safety and efficacy of potential COVID-19 vaccines. More specifically, the agency requires that scientific evidence for regulatory approval must come from large, high quality clinical trials that are randomized and observer-blinded, with an expectation of appropriately designed studies with significant numbers of participants across diverse populations.” 3296

As we head into cold and flu season, you can expect things will be handled differently at workplaces, schools, day cares and medical offices because of COVID-19.Anyone with symptoms like a runny nose, a cough or sneezing will likely be asked to stay home.“So, I think there's going to be a requirement for any of these symptoms for employee health at the workplace to take a larger role in screening patients probably a lot more testing,” said Dr. Scott Joy, Chief Medical Officer at Englewood Primary Care.Joy spoke with us about how people should handle these symptoms during the COVID-19 pandemic. He recommends staying home for 24 hours when you have a cold without a fever.If you have a fever, isolate for up to six days or until you've been fever free for a full 24 hours. If you're coughing or sneezing more than four times in an hour, you should probably stay home and see a doctor.“We haven't had a metric like that before, so we're going to experiment with that data point and see what it does to our workforce and our clinic infection control over this season,” said Joy.Joy also reminds people to get the flu shot.A study in the New England Journal of Medicine found people who got the vaccine had 25% fewer episodes of upper respiratory infections than those who didn't. That means fewer sick days from work and fewer doctor visits.The hope is that COVID-19 measures like handwashing, mask wearing and watching your distance will lead to fewer respiratory infections overall. But should you experience those symptoms, you may be directed to urgent care centers instead.The idea is to keep doctor offices sterile, so people with chronic conditions and other issues feel safe coming in to see their primary care physician.“In the last couple of months, people that have been putting off their care, I just diagnosed a gentleman, new diagnosis with pancreatic cancer,” said Joy. “We're detecting breast cancer, heart disease blood pressure that is out of control.”Urgent care centers are equipped with personal protective equipment and are typically faster, and cheaper than a visit to a hospital emergency room. But you should call your doctor's office first to see what they recommend based on your symptoms. 2228

来源：资阳报